SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAukett Swanke Regulatory News (AUK)

  • There is currently no data for AUK

Trading Statement

13 Feb 2009 07:00

RNS Number : 2500N
Aukett Fitzroy Robinson Group PLC
13 February 2009
 



For release at 07.00, February 13, 2009

Aukett Fitzroy Robinson Group plc 

("Aukett" or the "Company)

TRADING UPDATE

RUSSIAN CONTRACT EXTENSION

In the recent preliminary results of 15th January the Company announced the signing of a 4,000,000 sq ft office complex for a major Russian financial institution. We are now pleased to advise that instructions have been received and a large advance payment made by the developer client to progress to a planning application this year. This will result in a significant uplift in the Russian operation's income and profits for the current year.

The board's stated intention has been to diversify revenue streams away from the deteriorating UK market and this has proved to be a successful strategy with good progress being made in both Russia and the Middle East. We continue to receive a number of enquires in Russia and have signed further project contracts in Moscow notwithstanding the fact that the Russian market is, in general, experiencing similar funding issues with property projects resulting in widespread deferrals of project starts.

The company stated in the recent preliminary results that it would be necessary to review the UK cost base in view of the decline in the UK market. The outlook for the UK has worsened since January with a number of projects experiencing delays. As a result further cost cuts have been made and the impact of this restructuring will be seen in the first half.

As a result of the continued growth in our overseas operations, compensating for the problems in the UK market, the Board remains confident that it will achieve market expectations for the full year. Due to the large advance payment from Russia, as referred to above, revenue will be increasingly dominated by non-UK based project income. 

Overall it is anticipated that improvement in second half profitability should more than offset the restructuring costs of the first half and the group will continue to be cash generative.

Nicholas Thompson

Chief Executive

Enquiries:

Aukett Fitzroy Robinson - 020 7636 8033Nicholas Thompson, Chief Executive OfficerDuncan Harper, Group Finance Director

FinnCap - 020 7600 1658Sam SmithClive Carver

Adventis Financial PR - 020 7034 4759 / 4758Chris SteeleTarquin Edwards

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMGGMZVZKGLZM
Date   Source Headline
3rd Mar 202510:30 amRNSChange of Name
14th Jan 202511:15 amRNSHolding(s) in Company
5th Dec 20241:08 pmRNSDirector and PCA Dealings
28th Nov 20247:00 amRNS-RNotice of presence at Anticipate London 2024
14th Nov 20247:00 amRNSChange of Auditor
18th Sep 20247:00 amRNSProperty disposal completion & Corporate update
20th Aug 20245:15 pmRNSHolding(s) in Company
20th Aug 20241:15 pmRNSHolding(s) in Company
6th Aug 20245:30 pmRNSHolding(s) in Company
1st Aug 202410:00 amRNSDirector Dealing
17th Jul 20247:00 amRNSHolding(s) in Company
15th Jul 20241:00 pmRNSAIM Rule 17 - Schedule 2(g) Update
5th Jul 20244:25 pmRNSProperty Disposal Update
28th Jun 20247:01 amRNSWarrant Exercise
28th Jun 20247:00 amRNSInterim Results
24th Jun 20247:00 amRNSProperty Disposal
4th Jun 202412:45 pmRNSSmart Buildings software contract win
29th May 20242:15 pmRNSIssue of Equity
9th May 20247:00 amRNSIssue of Warrants & Director/PDMR Notifications
26th Apr 20243:15 pmRNSResult of Annual General Meeting
26th Apr 20247:55 amRNSAGM Trading Statement
4th Apr 20247:00 amRNSSubscription Update & Director/PDMR Notifications
28th Mar 202411:52 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSFinal Results and Notice of AGM
27th Mar 202412:04 pmRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
21st Mar 20247:00 amRNSAcquisition, Subscription and Notice of Results
19th Feb 20247:00 amRNSArtificial Intelligence Consortium
14th Feb 202410:40 amRNSHolding(s) in Company
2nd Feb 20247:00 amRNSCommercial Update
4th Jan 20247:00 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSLaunch of Employee Share Purchase Plans
17th Nov 20232:32 pmRNSHolding(s) in Company
14th Nov 20239:02 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSAcquisition of TR Control Solutions Limited
10th Oct 202311:15 amRNSHolding(s) in Company
5th Oct 202312:01 pmRNSProperty marketed for sale
17th Jul 20237:00 amRNSAcquisition of Anders+Kern U.K. Limited
27th Jun 20237:05 amRNSAppointment of Chief Operating Officer
27th Jun 20237:00 amRNSInterim Results
27th Apr 20231:20 pmRNSHolding(s) in Company
24th Apr 20237:00 amRNSAppointment of Non-Executive Director
21st Apr 202311:45 amRNSResult of AGM and Board Changes
5th Apr 20233:15 pmRNSPosting of Notice of AGM and Annual Report
4th Apr 20237:00 amRNSDisposal of Live Events Business
28th Mar 20237:00 amRNSResults for the year ended 30 September 2022
21st Mar 20237:00 amRNSResult of GM, Board Change, Acquisition Completion
2nd Mar 20237:00 amRNSProposed Acquisition, Rule 9 Waiver and GM Notice
1st Feb 20234:53 pmRNSChange of Adviser
30th Jan 20234:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.